Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial

BACKGROUND/AIMS: Besifovir dipivoxil maleate (BSV), an acyclic nucleotide phosphonate, shows potent antiviral activity against hepatitis B virus. Our previous 48-week trial revealed that BSV has comparable antiviral efficacy to tenofovir disoproxil fumarate (TDF) and better safety profiles in terms...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Clin Mol Hepatol
Main Authors: Song, Do Seon, Kim, Won, Ahn, Sang Hoon, Yim, Hyung Joon, Jang, Jae Young, Kweon, Young Oh, Cho, Yong Kyun, Kim, Yoon Jun, Hong, Gun Young, Kim, Dong Joon, Jung, Young Kul, Sohn, Joo Hyun, Lee, Jin-Woo, Park, Sung Jae, Lee, Byung Seok, Kim, Ju Hyun, Kim, Hong Soo, Yoon, Seung Kew, Kim, Moon Young, Lee, Kwan Sik, Lim, Young Suk, Lee, Wan Sik, Yang, Jin Mo, Kim, Kyun-Hwan, Han, Kwang-Hyub, Um, Soon Ho
Format: Artigo
Sprog:Inglês
Udgivet: The Korean Association for the Study of the Liver 2021
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8046633/
https://ncbi.nlm.nih.gov/pubmed/33493393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2020.0307
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker